Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Barth

Showing results (381-390 of 400) with videos related to

Pageof 40
Sort By:
Gastroenterology|June 26, 2016
Detection of Hot-Spot Mutations in Circulating Cell-Free DNA From Patients With Intraductal Papillary Mucinous Neoplasms of the PancreasAndreas W Berger, Daniel Schwerdel, Ivan G Costa, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|August 17, 2004
Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agentRolf F Barth, Gong Wu, Weilian Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 7, 1998
SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptorM Rinaldi-Carmona, F Barth, J Millan, et al.
Pediatric Blood & Cancer|February 6, 2013
Persistent defective membrane trafficking in epithelial cells of patients with familial hemophagocytic lymphohistiocytosis type 5 due to STXBP2/MUNC18-2 mutationsPolina Stepensky, Jack Bartram, Thomas F Barth, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 6, 2013
Cellular influx, efflux, and anabolism of 3-carboranyl thymidine analogs: potential boron delivery agents for neutron capture therapyElena Sjuvarsson, Vijaya L Damaraju, Delores Mowles, et al.
Gene Therapy|September 25, 1998
Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vectorU Herrlinger, C M Kramm, K S Aboody-Guterman, et al.
Gene Therapy|August 10, 2002
In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomasJ-Y Cho, D H Y Shen, W Yang, et al.
Cancer Research|March 5, 2003
Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphomaSameek Roychowdhury, Ruoqi Peng, Robert A Baiocchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Molecular targeting and treatment of composite EGFR and EGFRvIII-positive gliomas using boronated monoclonal antibodiesWeilian Yang, Gong Wu, Rolf F Barth, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|September 30, 2016
An obesity paradox: an inverse correlation between body mass index and atherosclerosis of the aortaSergey V Brodsky, Rolf F Barth, Xiaokui Mo, et al.
Pageof 40

Showing results (381-390 of 400) with videos related to

Sort By:
Pageof 40
Gastroenterology|June 26, 2016
Detection of Hot-Spot Mutations in Circulating Cell-Free DNA From Patients With Intraductal Papillary Mucinous Neoplasms of the PancreasAndreas W Berger, Daniel Schwerdel, Ivan G Costa, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|August 17, 2004
Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agentRolf F Barth, Gong Wu, Weilian Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 7, 1998
SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptorM Rinaldi-Carmona, F Barth, J Millan, et al.
Pediatric Blood & Cancer|February 6, 2013
Persistent defective membrane trafficking in epithelial cells of patients with familial hemophagocytic lymphohistiocytosis type 5 due to STXBP2/MUNC18-2 mutationsPolina Stepensky, Jack Bartram, Thomas F Barth, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 6, 2013
Cellular influx, efflux, and anabolism of 3-carboranyl thymidine analogs: potential boron delivery agents for neutron capture therapyElena Sjuvarsson, Vijaya L Damaraju, Delores Mowles, et al.
Gene Therapy|September 25, 1998
Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vectorU Herrlinger, C M Kramm, K S Aboody-Guterman, et al.
Gene Therapy|August 10, 2002
In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomasJ-Y Cho, D H Y Shen, W Yang, et al.
Cancer Research|March 5, 2003
Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphomaSameek Roychowdhury, Ruoqi Peng, Robert A Baiocchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Molecular targeting and treatment of composite EGFR and EGFRvIII-positive gliomas using boronated monoclonal antibodiesWeilian Yang, Gong Wu, Rolf F Barth, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|September 30, 2016
An obesity paradox: an inverse correlation between body mass index and atherosclerosis of the aortaSergey V Brodsky, Rolf F Barth, Xiaokui Mo, et al.
Pageof 40